The molecular regulation of myogenesis

Clinical Genetics

Volumn 57, Issue 1, 2000, Pages 16-25

  Sabourin, Luc A ^a   Rudnicki, Michael A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MYOGENIC FACTOR; MYOGENIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; CELL ACTIVATION; CELL CYCLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL LINEAGE; CELL PROLIFERATION; CHROMATIN STRUCTURE; CLINICAL GENETICS; EMBRYO; EMBRYO DEVELOPMENT; GENE ACTIVATION; GENE INACTIVATION; HUMAN; HUMAN CELL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SATELLITE CELL; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINEAGE; DNA-BINDING PROTEINS; GENE SILENCING; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MUSCLES; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; MYOGENIC REGULATORY FACTORS; MYOGENIN; REGENERATION; TRANS-ACTIVATORS;

ANIMALIA;

EID: 0033952368     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0004.2000.570103.x     Document Type: Review

References (107)

1. Olson EN, Klein WH. bHLH factors in muscle development: dead lines and commitments, what to leave in and what to leave out. Genes Dev 1994: 8: 1-8.
2. Rudnicki MA, Jaenisch R. The MyoD family of transcription factors and skeletal myogenesis. Bioessays 1995: 17: 203-209.
3. Weintraub H, Davis R, Tapscott S et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991: 251: 761-766.
4. Davis RL, Weintraub H, Lassar AB. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987: 51: 987-1000.
5. Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. Embo J 1989: 8: 701-709.
6. Edmondson DG, Olson EN. A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev 1989: 3: 628-640.
7. Braun T, Bober E, Winter B, Rosenthal N, Arnold HH. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. Embo J 1990: 9: 821-831.
8. Miner JH, Wold B, Herculin, a fourth member of the MyoD family of myogenic regulatory genes. Proc Natl Acad Sci USA 1990: 87: 1089-1093.
9. Rhodes SJ, Konieczny SF. Identification of MRF4: a new member of the muscle regulatory factor gene family. Genes Dev 1989: 3: 2050-2061.
10. Emerson CP Jr. Skeletal myogenesis: genetics and embryology to the fore. Curr Opin Genet Dev 1993: 3: 265-274.
11. Buckingham M. Skeletal muscle development and the role of the myogenic regulatory factors. Biochem Soc Trans 1996: 24: 506-509.
12. Buckingham M, Cossu G. Myogenesis in the mouse embryo. Methods Cell Biol 1997: 52: 29-52.
13. Ott MO, Bober E, Lyons G, Arnold H, Buckingham M. Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo. Development 1991: 111: 1097-1107.
14. Sassoon D, Lyons G, Wright WE et al. Expression of two myogenic regulatory factors myogenin and MyoD1 during mouse embryogenesis. Nature 1989: 341: 303-307.
15. Bober E, Lyons GE, Braun T et al. The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development. J Cell Biol 1991: 113: 1255-1265.
16. Cheng TC, Tseng BS, Merlie JP, Klein WH, Olson EN. Activation of the myogenin promoter during mouse embryogenesis in the absence of positive autoregulation. Proc Natl Acad Sci USA 1995: 92: 561-565.
17. Cheng TC, Wallace MC, Merlie JP, Olson EN. Separable regulatory elements governing myogenin transcription in mouse embryogenesis. Science 1993: 261: 215-218.
18. Asakura A, Lyons GE, Tapscott SJ. The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev Biol 1995: 171: 386-398.
19. Faerman A, Goldhamer DJ, Puzis R, Emerson CP Jr, Shani M. The distal human myoD enhancer sequences direct unique muscle-specific patterns of lacZ expression during mouse development. Dev Biol 1995: 171: 27-38.
20. Goldhamer DJ, Faerman A, Shani M, Emerson CP Jr. Regulatory elements that control the lineage-specific expression of myoD. Science 1992: 256: 538-542.
21. Goldhamer DJ, Brunk BP, Faerman A et al. Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 1995: 121: 637-649.
22. Tapscott SJ, Lassar AB, Weintraub H. A novel myoblast enhancer element mediates MyoD transcription. Mol Cell Biol 1992: 12: 4994-5003.
23. Yee SP, Rigby PW. The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev 1993: 7: 1277-1289.
24. Kucharczuk KL, Love CM, Dougherty NM, Goldhamer DJ. Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and non-myotomal muscle lineages. Development 1999: 126: 1957-1965.
25. Brunk BP, Goldhamer DJ, Emerson CP Jr. Regulated demethylation of the myoD distal enhancer during skeletal myogenesis. Dev Biol 1996: 177: 490-503.
26. Tajbakhsh S, Rocancourt D, Cossu G, Buckingham M. Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 1997: 89: 127-138.
27. Tajbakhsh S, Cossu G. Establishing myogenic identity during somitogenesis. Curr Opin Genet Dev 1997: 7: 634-641.
28. Maroto M, Reshef R, Munsterberg AE et al. Ectopic Pax-3 activates MyoD and Myf-5 expression in embryonic mesoderm and neural tissue. Cell 1997: 89: 139-148.
29. Epstein JA, Lam P, Jepeal L, Maas RL, Shapiro DN. Pax3 inhibits myogenic differentiation of cultured myoblast cells. J Biol Chem 1995: 270: 11719-11722.
30. Rudnicki MA, Braun T, Hinuma S, Jaenisch R. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 1992: 71: 383-390.
31. Braun T, Rudnicki MA, Arnold HH, Jaenisch R. Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell 1992: 71: 369-382.
32. Wang Y, Jaenisch R. Myogenin can substitute for Myf5 in promoting myogenesis but less efficiently. Development 1997: 124: 2507-2513.
33. Wang Y, Schnegelsberg PN, Dausman J, Jaenisch R. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin. Nature 1996: 379: 823-825.
34. Rudnicki MA, Schnegelsberg PN, Stead RH et al. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993: 75: 1351-1359.
35. Hasty P, Bradley A, Morris JH et al. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 1993: 364: 501-506.
36. Nabeshima Y, Hanaoka K, Hayasaka M et al. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 1993: 364: 532-535.
37. Braun T, Arnold HH. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. Embo J 1995: 14: 1176-1186.
38. Patapoutian A, Yoon JK, Miner JH et al. Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development 1995: 121: 3347-3358.
39. Zhang W, Behringer RR, Olson EN. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anomalies. Genes Dev 1995: 9: 1388-1399.
40. Weintraub H. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 1993: 75: 1241-1244.
41. Kablar B, Krastel K, Ying C et al. MyoD and Myf-5 differentially regulate the development of limb versus trunk skeletal muscle. Development 1997: 124: 4729-4738.
42. Murre C, McCaw PS, Vaessin H et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989: 58: 537-544.
43. Murre C, McCaw PS, Baltimore D. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 1989: 56: 777-783.
44. Lassar AB, Davis RL, Wright WE et al. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 1991: 66: 305-315.
45. Benezra R, Davis RL, Lassar A et al. Id: a negative regulator of helix-loop-helix DNA binding proteins. Control of terminal myogenic differentiation. Ann NY Acad Sci 1990: 599: 1-11.
46. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990: 61: 49-59.
47. Spicer DB, Rhee J, Cheung WL, Lassar AB. Inhibition of myogenic bHLH and MEF2 transcription factors by the bHLH protein Twist [see comments]. Science 1996: 272: 1476-1480.
48. Lemercier C, To RQ, Carrasco RA, Konieczny SF. The basic helix-loop-helix transcription factor Mistl functions as a transcriptional repressor of myoD. Embo J 1998: 17: 1412-1422.
49. Olson EN. Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol 1992: 154: 261-272.
50. Lassar AB, Skapek SX, Noviteh B. Regulatory mechanisms that coordinate skeletal muscle differentiation and cell cycle withdrawal. Curr Opin Cell Biol 1994: 6: 788-794.
51. Gu W, Schneider JW, Condorelli G et al. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993: 72: 309-324.
52. Guo K, Wang J, Andres V, Smith RC, Walsh K. MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol 1995: 15: 3823-3829.
53. Halevy O, Novitch BG, Spicer DB et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995: 267: 1018-1021.
54. Schneider JW, Gu W, Zhu L, Mahdavi V, Nadal-Ginard B. Reversal of terminal differentiation mediated by p107 in Rb- - muscle cells. Science 1994: 264: 1467-1471.
55. Parker SB, Eichele G, Zhang P et al. p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 1995: 267: 1024-1027.
56. Skapek SX, Rhee J, Kim PS, Novitch BG, Lassar AB. Cyclin-mediated inhibition of muscle gene expression via a mechanism that is independent of pRB hyperphosphorylation. Mol Cell Biol 1996: 16: 7043-7053.
57. Skapek SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995: 267: 1022-1024.
58. Zhang JM, Wei Q, Zhao X, Paterson BM. Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4. Embo J 1999: 18: 926-933.
59. Bengal E, Ransone L, Scharfmann R et al. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 1992: 68: 507-519.
60. Li L, Chambard JC, Karin M, Olson EN. Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev 1992: 6: 676-689.
61. Trouche D, Grigoriev M, Lenormand JL et al. Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature 1993: 363: 79-82.
62. La Rocca SA, Crouch DH, Gillespie DA. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 1994: 9: 3499-3508.
63. Miner JH, Wold BJ. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol Cell Biol 1991: 11: 2842-2851.
64. Kong Y, Johnson SE, Taparowsky EJ, Konieczny SF. Ras p21Va1 inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors. Mol Cell Biol 1995: 15: 5205-5213.
65. Konieczny SF, Drobes BL, Menke SL, Taparowsky EJ. Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene. Oncogene 1989: 4: 473-481.
66. Olson EN, Spizz G, Tainsky MA. The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation. Mol Cell Biol 1987: 7: 2104-2111.
67. Taylor DA, Kraus VB, Schwarz JJ, Olson EN, Kraus WE. E1A-mediated inhibition of myogenesis correlates with a direct physical interaction of E1A12S and basic helix-loop-helix proteins. Mol Cell Biol 1993: 13: 4714-4727.
68. Braun T, Bober E, Arnold HH. Inhibition of muscle differentiation by the adenovirus E1a protein: repression of the transcriptional activating function of the HLH protein Myf-5. Genes Dev 1992: 6: 888-902.
69. Li L. Zhou J, James G et al. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains. Cell 1992: 71: 1181-1194.
70. Li L, Heller-Harrison R, Czech M, Olson EN. Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins. Mol Cell Biol 1992: 12: 4478-4485.
71. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ, Bengal E. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J Biol Chem 1998: 273: 10436-10444.
72. Bennett AM, Tonks NK. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 1997: 278: 1288-1291.
73. Weyman CM, Wolfman A. Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 1998: 139: 1794-1800.
74. Cuenda A, Cohen P. Stress-activated protein kinase-2/ p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 1999: 274: 4341-4346.
75. Sartorelli V, Huang J, Hamamori Y, Kedes L. Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol 1997: 17: 1010-1026.
76. Yuan W, Condorelli G, Caruso M, Felsani A, Giordano A. Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem 1996: 271: 9009-9013.
77. Eckner R, Yao T-P, Oldread E, Livingston DM. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev 1996: 10: 2478-2490.
78. Puri PL, Sartorelli V, Yang XJ et al. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1997: 1: 35-45.
79. Gerber AN, Klesert TR, Bergstrom DA, Tapscott SJ. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev 1997: 11: 436-450.
80. Anand G, Shapiro DN, Dickman PS, Prochownik EV. Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors. J Clin Invest 1994: 93: 5-9.
81. Fiddler TA, Smith L, Tapscott SJ, Thayer MJ. Amplification of MDM2 inhibits MyoD-mediated myogenesis. Mol Cell Biol 1996: 16: 5048-5057.
82. Tapscott SJ, Thayer MJ, Weintraub H. Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 1993: 259: 1450-1453.
83. Heller H, Bengal E. TFIID (TBP) stabilizes the binding of MyoD to its DNA site at the promoter and MyoD facilitates the association of TFIIB with the preinitiation complex. Nucleic Acids Res 1998: 26: 2112-2119.
84. Kong Y, Flick MJ, Kudla AJ, Konieczny SF. Muscle L1M protein promotes myogenesis by enhancing the activity of MyoD. Mol Cell Biol 1997: 17: 4750-4760.
85. Olson EN, Perry M, Schulz RA. Regulation of muscle differentiation by the MEF2 family of MADS box transcription factors. Dev Biol 1995: 172: 2-14.
86. Molkentin JD, Black BL, Martin JF, Olson EN. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins. Cell 1995: 83: 1125-1136.
87. Molkentin JD, Olson EN. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proc Natl Acad Sci USA 1996: 93: 9366-9373.
88. Groisman R, Masutani H, Leibovitch MP et al. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins. J Biol Chem 1996: 271: 5258-5264.
89. Bischoff R. The satellite cell and muscle regeneration. In: Engel AG, Franszini-Armstrong C, eds. Myogenesis, vol. 2. New York: McGraw-Hill, 1994: 97-118.
90. Grounds MD. Towards understanding skeletal muscle regeneration. Pathol Res Pract 1991: 187: 1-22.
91. Miller JB, Schaefer L, Dominov JA. Seeking muscle stem cells. Curr Top Dev Biol 1999: 43: 191-219.
92. Grounds MD, Yablonka-Reuveni Z. Molecular and cell biology of skeletal muscle regeneration. Mol Cell Biol Hum Dis Ser 1993: 3: 210-256.
93. Bulfield G, Siller WG, Wight PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984: 81: 1189-1192.
94. Webster C, Blau HM. Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: implications for cell and gene therapy. Somat Cell Mol Genet 1990: 16: 557-565.
95. Grounds DM. Age-associated changes in the response of skeletal muscle cells to exercise and regeneration. Ann NY Acad Sci 1998: 854: 78-91.
96. Cornelison DD, Wold BJ. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol 1997: 191: 270-283.
97. Yablonka-Reuveni Z, Rivera AJ. Temporal expression of regulatory and structural muscle proteins during myogenesis of satellite cells on isolated adult rat fibers. Dev Biol 1994: 164: 588-603.
98. Smith CK II, Janney MJ, Allen RE. Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physiol 1994: 159: 379-385.
99. Cossu G, Tajbakhsh S, Buckingham M. How is myogenesis initiated in the embryo? Trends Genet 1996: 12: 218-223.
100. Megeney LA, Kablar B, Garrett K, Anderson JE, Rudnicki MA. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev 1996: 10: 1173-1183.
101. Megeney LA, Kablar B, Perry RL et al. Severe cardiomyopathy in mice lacking dystrophin and MyoD. Proc Natl Acad Sci USA 1999: 96: 220-225.
102. Sabourin LA, Girgis-Gabardo A, Seale P, Asakura A, Rudnicki MA. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J Cell Biol 1999: 144: 631-643.
103. Allen RE, Sheehan SM, Taylor RG, Kendall TL, Rice GM. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol 1995: 165: 307-312.
104. George-Weinstein M, Foster RF, Gerhart JV, Kaufman SJ. In vitro and in vivo expression of alpha 7 integrin and desmin define the primary and secondary myogenic lineages. Dev Biol 1993: 156: 209-229.
105. Yablonka-Reuveni Z, Rudnicki MA, Rivera AJ et al. The transition from proliferation to differentiation is delayed in satellite cells from mice lacking MyoD. Dev Biol 1999: 210: 440-455.
106. Zeschnigk M, Kozian D, Kuch C, Schmoll M, Starzinski-Powitz A. Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J Cell Sci 1995: 108: 2973-2981.
107. Irintchev A, Zeschnigk M, Starzinski-Powitz A, Wernig A. Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev Dyn 1994: 199: 326-337.